Innoviva Inc (HVE.BE)
Berlin - Berlin Delayed price. Currency in EUR
Add to watchlist
As of 08:08AM CEST. Market open.
| Previous close | 17.90 |
| Open | 17.80 |
| Bid | 17.60 x 0 |
| Ask | 17.80 x 0 |
| Day's range | 17.80 - 17.80 |
| 52-week range | 11.50 - 17.90 |
| Volume | |
| Avg. volume | 0 |
| Market cap | N/A |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | 30 Oct 2024 - 04 Nov 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
Simply Wall St.Innoviva, Inc.'s (NASDAQ:INVA) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?
Most readers would already be aware that Innoviva's (NASDAQ:INVA) stock increased significantly by 17% over the past...
Business WireInnoviva to Participate in Upcoming Investor Conferences
BURLINGAME, Calif., September 04, 2024--Innoviva, Inc. (NASDAQ: INVA) ("Innoviva" or the "Company"), a diversified holding company with a core royalties portfolio, a leading critical care and infectious disease platform known as Innoviva Specialty Therapeutics ("IST"), and a portfolio of strategic investments in healthcare assets, today announced that management will participate in the following upcoming investor conferences in September:
- Associated Press Finance
Innoviva: Q2 Earnings Snapshot
BURLINGAME, Calif. AP) — Innoviva Inc. INVA) on Wednesday reported a loss of $34.7 million in its second quarter.
© 2024 Yahoo. All rights reserved.